A problem in generating artificial tissues is supplying nutrients to cells within 3D constructs. The use of a decellularized biological vascularized matrix with preserved pedicles (BioVaM), as a scaffold, appears to aid the generation of perfusable tissue constructs in vitro. To prevent vessel occlusion upon implantation, a functional endothelium must line the graft vessel bed. Here we tested whether the pro-angiogenic factor CCN1 could improve the re-endothelialization of BioVaM in vitro.
Introduction
Tissue engineering (TE) is a promising technique for future therapeutic approaches especially for cardiac reconstruction, as myocardial infarct and co-morbidities remain one of the leading causes of death in modern society. 1 A persistent obstacle to the generation of 3D tissues for therapeutic application is the efficient substrate supply and subsequent † Present address: Department of Cardiac Surgery, Lahr Heart Institute, Lahr, Germany.
removal of culture waste products of cells seeded inside complex cell matrix constructs. Depending on the architecture and stiffness of the reverse engineered tissue, a more or less intense supply of substrates and oxygen must be provided to the constructs, as inherent diffusion processes are limiting with increases in tissue thickness. 2 Indeed, this is a substantial problem in cardiac TE, due in part to the fact that cardiac muscle is dense and has the highest oxygen consumption of all organs, but has little extracellular matrix content. 3 Thus, in vivo, each individual cardiomyocyte is connected to at least one capillary. As a result, only cardiac tissue thicknesses ranging from 40 4 to 100 mm 5 can be perfused using available TE methods. Several efforts have been made to solve this problem: (i) porous scaffolds or channelled matrices to promote diffusion processes inside tissues after seeding cells; 6, 7 (ii) employment of devices, for example, rotating wall vessels or stirrers 8 to enhance convection in the tissue surrounded by media; and (iii) the use of oxygen carrying molecules or moieties to enhance oxygen concentration within polymeric scaffolds. 9 -12 Despite improvement, these approaches have not solved the problem of constricted diffusion inside the artificial cardiac tissue.
Since therapeutically relevant ischaemic situations in the heart usually occur in the left ventricle, an applicable TE myocardial patch would need to have a thickness of millimeters. However, to date, no complex cardiac tissue has been created with a thickness greater than 100 mm. 13 Overcoming this obstacle would be best accomplished by supplying nutrients via in vitro and/or an in vivo vascularization, a system already established in nature. 14, 15 To this point, we have employed biological vascularized matrix (BioVaM), a highly perfusable matrix generated from decellularized porcine small intestine segments with preserved pedicles and vessel network, as an in vitro vascularization system. 16 In 2005, first steps towards the re-seeding of BioVaM vessel structures were conducted at our institution. 17 Despite promising results, it was evident that the seeding process required improvements, as an incomplete endothelial lining of the vessel bed of the BioVaM would be highly thrombogenic when connected to the blood stream in vivo.
To enhance the re-seeding process, we generated a new perfusion bioreactor system that uses BioVaM as a patch. Furthermore, we investigated whether the coating of the BioVaM vessel structures with the secreted matrix associated protein, CCN1, would additionally support and promote adhesion, migration, proliferation, and survival of endothelial cells as previously reported 18 -24 (reviewed by Brigstock et al. 25 and Chen et al.
26
). Herein, we report an improvement in the repopulation properties by coating BioVaM vessel structures with CCN1.
Methods
All reagents were purchased from Merck (Darmstadt, Germany) and Sigma-Aldrich (Munich, Germany). All experiments were conducted at room temperature unless otherwise indicated.
2.1 Cell culture: isolation, differentiation, and culture of human cord blood-derived endothelial cells
Mononuclear cells were obtained from heparinized human umbilical cord blood (obtained from healthy newborn donors after informed parental consent) by density gradient centrifugation on Ficoll-Hypaque (Seromed). CD34 þ progenitor cells were isolated by immunomagnetic separation using anti-CD34 antibody-linked immunomagnetic microbeads and double separation on a magnetic column (MACS system, Miltenyi Biotec) according to a protocol described previously by Murohara et al. 27 Isolated CD34 þ endothelial progenitor cells were cultured using a protocol described by Gehling et al. 28 with slight modifications. In detail, cord blood-derived CD34 þ cells of 2 -3 donors were pooled, seeded on fibronectin-coated plastic plates, and cultured in IMDM with both 10% horse serum and foetal calf serum supplemented with 50 ng/mL recombinant human stem cell factor (R&D), 50 ng/mL vascular endothelial growth factor (R&D), 20 ng/mL fibroblast growth factor-2 (R&D), and 100 ng/mL stem cell growth factor (SCGF-b, PeproTech). Adherent endothelial cell clusters were observed at week 1-2 of culture. Cells were adapted to endothelial cell basal medium (EBM-2) with 2% FCS and growth factor supplement (EGM-2, Lonza). For all experiments, human cord blood-derived endothelial cells (hCBEC) were cultured in gelatincoated culture flasks in EGM-2/10% FCS/1% antibiotics. Medium was exchanged every 3 days (d).
CCN1 influence on hCBEC attachment
As hCBEC have been extensively characterized previously, we sought to determine the effect of CCN1 on hCBEC attachment in culture plates, prior to initiating BioVaM experiments. In brief, six-well plates were pre-coated with 1% gelatin alone or with 1% gelatin enriched with either 10 or 100 ng/mL CCN1. After overnight incubation, wells were rinsed with phosphate buffered saline (PBS). hCBEC were then seeded onto wells with an average density of 3.5 Â 10 5 cells/cm 2 . Cells were incubated for 10, 20, 30, or 75 min, trypsinized, and counted using CASY R excell (Innovates AG, Reutlingen, Germany). To confirm that CCN1 binds via integrins, cells were pretreated for 30 min at 378C with 1 mM RGD peptide (Arg-Gly-Asp, Bachem), a non-specific integrin inhibitor, prior to seeding on above described six-well plates. Data are presented as the % of total cells initially seeded into the wells.
BioVaM preparation
Segments of small intestine with preserved pedicles (BioVaM) were isolated from German landrace pigs (18 -25 kg) as previously described. 17 All animals used in this study received humane care in compliance with the Guide for Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No.85-23, revised 1996). The study was approved by the local Animal Care and Research Advisory Committee and was conducted according to local government policy (#05/937). In brief, a median laparotomy on anaesthetized animals (propofol, 10 mg/kg i.v.; thiopental sodium, 5 mg/kg i.v.; fentanyl citrate, 0.1 mg/kg i.v.) was used to isolate a 10 -15 cm long segment of jejunum, including the artery and vein pedicle. Anticoagulation was achieved by systemic application of heparin (150 IE/kg). Following insertion of a 6 F catheter into the artery and an 8 F catheter into the vein, the vessel system was perfused with saline (0.9% NaCl) supplemented with vancomycin (1 g/L; ratiopharm). After excision of the segment, the explants were stored in undiluted Braunol (B. Braun) at 48C for 60 min until further processing (described below). The animal was then euthanized with sodiumpentobarbital (90 mg/kg, i.v.). The mucosa of the BioVaM grafts was removed mechanically by scraping the inner lumen of the intestine. This was followed by the detergent decellularization of the BioVaM (2 h; 0.5% sodium deoxycholate and 0.5% sodium dodecylsulfate), seven wash cycles at 48C CCN1 improves vascularized matrix endothelialization (24 h each) with PBS supplemented with Nebacitin (100 mg/mL, Biochrom) for removal of remaining detergents and cell debris were performed. Decellularized matrices were stored in PBS/Nebacitin at 48C.
For seeding, the BioVaM was cut open along the longitudinal axis opposite to the hanging mesentary, after the serosa was removed mechanically. The resulting patch was sutured (Mersilene 5/0; Ethicon) to a silicon rubber cushion made from a two-component silicon mixture (RTV 71556A and B, Rhodia Silicones, France) cast with the dimensions of 5 Â 3 cm. The orientation was such that the serosa side with mesentery was turned up towards the environment, whereas the submucosa side was turned down towards the cushion. The constructs were then sterilized by g-irradiation (150 Gy) and stored in PBS/Nebacitin at 48C.
Constructs treated with CCN1 (cBioVaM; n ¼ 7) were compared with constructs without CCN1 (BioVaM: n ¼ 8). For CCN1 exposure, the vessel system of the BioVaM was infused through the arterial cannula with 100 ng/mL recombinant human CCN1 (Abnova) in culture medium (EBM-2, Lonza) and incubated overnight (12 h; 378C). Unbound CCN1 was removed 12 h after incubation by rinsing the vessel system with warm DMEM containing 1% penicillin -streptomycin (378C). After rinsing, the seeding procedure was initiated.
Seeding and culture of hCBEC in BioVaM
Constructs were seeded by the injection of 0.8 Â 10 7 hCBEC in 10 mL EBM-2 through the arterial cannula, twice in a 4 h interval (0.5 mL of in-flow and 0.5 mL of off-flow was used to determine the seeding efficiency, see below). In some cases (BioVaM: n ¼ 4 and cBioVaM: n ¼ 4), cells were fluorescence labelled prior to seeding, by incubation with 25 mM 5(6)-TAMRA, SE (Molecular Probes) in PBS for 20 min at 378C, 5% CO 2 and 100% relative humidity. Perfusion cultivation in a bioreactor device was initiated 12 h after seeding (medium: EGM-2/ 10% FCS/1% PS; medium volume: 200 mL; flow: 2 mL/min). As the mucosa was removed, submucosal vessels (arterioles and capillaries) were leaky and thus, the outflow was re-circulated through a pump (Ismatec). BioVaM and cBioVaM constructs were cultivated for 4 d (n ¼ 4, each) and 14 d (n ¼ 3, each).
Seeding efficiency
The ratio of the number of cells cultivated from 0.5 mL in-flow and 0.5 mL out-flow at each seeding, cultivated for 12 h in a 25 T culture flask was used to determine the efficiency of living cells retained in both the BioVaM (n ¼ 3) and cBioVaM (n ¼ 3).
Dil-Ac-LDL assay
At the end of cultivation (4 and 14 d), a Dil-Ac-LDL uptake test was performed. 29 Constructs (n ¼ 1 from each condition) were perfused with 10 mg/mL Dil-Ac-LDL in EGM-2 and cultivated statically for 4 h at 378C, washed with PBS, and fixed with 4% paraformaldehyde (PFA) for 20 min in the dark. Results were evaluated microscopically (fluorescence microscope Observer A1, Zeiss).
DNA content
DNA was isolated with the DNA Blood and Tissue Easy Kit (Qiagen) from homogenized constructs (BioVaM: n ¼ 3 and cBioVaM: n ¼ 3) (FastPrep w -24 System, MP Biomedicals) according to the manufacturer's protocol. DNA content was measured photometrically.
Measurement of cultivation parameters
Oxygen saturation and pH were measured using a CDI 500 blood gas analyser (Terumo) according to the manufacturer's protocol. Lactic acid measurement (n ¼ 3 BioVaMs/group) was assessed with a YSI 2300 STAT Glucose and Lactate Analyzer.
Histology and immunohistochemistry
Cryosections (6 mm) of constructs were stained with either haematoxylin -eosin (H&E) stain or pentachrome stain and visualized in a bright field (OlympusBX41 microscope). Cryosections were also assessed immunohistochemically with the following primary antibodies: Rabbit anti-laminin, mouse anti-collagen IV, mouse anti-von Willebrand Factor (vWF), mouse anti-CD31 (all DAKO), mouse antiendothelial nitric oxide synthase (eNOS) (Beckton Dickinson and Company), goat anti-CCN1 (Santa Cruz Biotechnologies). Cyanineconjugated donkey anti-mouse, anti-goat, and anti-rabbit antibodies (Jackson Research) served as secondary antibodies. Negative controls with the omission of the primary antibodies were used. Nuclear staining was performed with 4 0 ,6-diamidino-2-phenylindole, dichloride (DAPI). Sections were analysed and documented with fluorescence microscopy (Observer A1, Zeiss).
Statistics
Data are reported as mean + standard deviation. The t-test analyses were performed in Excel (Microsoft Office) and two-way ANOVA was performed using GraphPad Prism. A P-value of less than 0.05 was considered significant.
Results

CCN1 increases hCBEC adhesion
The positive effect of CCN1 on hCBEC adherence with respect to concentration (CCN1) is given in Figure 1 . Gelatin coating enriched Figure 1 Enhancement of adhesion properties of hCBEC with CCN1. Wells of a six-well plate were coated with either 1% gelatin or 1% gelatin enriched with 10 or 100 ng/mL CCN1. Similarly, wells were treated with hCBEC with or without preincubation with RGD, a non-specific inhibitor of integrins. A two-way ANOVA was performed on cells without RGD to assess effect of CCN1 on hCBEC adhesion. Asterisk denotes a significant increase (P , 0.05) in adhered cells observed after 30 and 75 min relative to gelatin coating only (n ¼ 5).
with 100 ng/mL CCN1 increased the amount of hCBEC adhering to the wells. Specifically, a significant increase in adhered cells was observed after 30 and 75 min relative to gelatin coating only. As expected, RGD inhibited the adhesion effect of CCN1 via inhibiting the interactions with integrins (Figure 1 ).
Characterization of decellularized BioVaM
Detergent-treated BioVaM was free of nuclei as demonstrated by H&E stains (Figure 2A) and showed a well-preserved ECM as determined by pentachrome staining (data not shown). These data correlate with positive immunohistochemical stains for the basal lamina proteins: collagen IV ( Figure 2B ) and laminin ( Figure 2C ), further indicative of structure preservation. Adherence to the vessel bed of CCN1 by overnight incubation was shown by immunohistochemistry against CCN1 in cBioVaM. Positive fluorescence signals were detectable on the luminal side of the vessel bed, but not inside the matrix structure ( Figure 2D and E).
CCN1 lining of the vessel bed in decellularized BioVaM improves repopulation dynamics of hCBEC
Upon seeding hCBEC into the vessel structures, significantly more cells were retained in cBioVaM than in BioVaM (84 + 9% vs. 47 + 4%, n ¼ 3, P , 0.05) ( Figure 3A) . Consistently, significantly more H&E staining of decellularized BioVaM shows no remaining nuclei or cell residues inside the matrix (A). Immunohistochemistry against collagen IV (B) and laminin (C) revealed the preservation of both basal lamina proteins on the luminal side of the vessel structures after decellularization. Successful coating of the vessel walls with CCN1 was demonstrated by immunohistochemistry against CCN1 in cBioVaM (D), whereas uncoated BioVaM showed no immunoreactive CCN1 protein (E). Figure 3 Re-seeding efficiency of BioVaM is increased by the CCN1 lining of vessel structures. A higher percentage of hCBEC is retained in BioVaM structures coated with CCN1, **P , 0.01 cBioVaM (n ¼ 3) vs. BioVaM (n ¼ 3) (A). Similarly, 12 h after re-seeding, cBioVaM (n ¼ 3) had a higher DNA content when compared with BioVaM (n ¼ 3), **P , 0.01 (B).
CCN1 improves vascularized matrix endothelialization DNA was isolated 12 h after seeding from cBioVaM compared with BioVaM (37 + 2 mg/g vs. 11 + 3 mg/g, n ¼ 3, P , 0.001) ( Figure 3B ). There was no DNA detected from the decellularized BioVaM.
The effect of CCN1 and cultivation duration (4 vs. 14 d) on vessel endothelialization was evaluated. On the basis of an arbitrary quantification system, the microscopic appearance of the repopulation success was rated ( Table 1) . As a result, both pretreatment with CCN1 and perfusion duration had a significant effect on vessel status (two-way ANOVA: *P CCN1 ¼ 0.028, † P time ¼ 0.002; n ¼ 3 for all groups).
After 4 d of perfusion cultivation in a bioreactor, fluorescent microscopy revealed linear, re-populated vessel structures with a maximum length of 1000 mm within BioVaM ( Figure 4A) , whereas in cBioVaM vessel structures with a maximum length of 2500 mm were observed ( Figure 4B) . The observational assessment of re-endothelialization after 4 d in BioVaM resulted in a mean value of 2.6 + 0.8 AU (n ¼ 3) and in cBioVaM 4.0 + 0.8 AU (n ¼ 3) ( Table 1 and cBioVaM, respectively ( Figure 5A ). Despite the increase in lactate in cBioVaM, no differences in oxygen saturation, which was 99% throughout the experiment, nor pH values, decreasing from 7.4 + 0.2 to 7.2 + 0.3, were observed between either BioVaM or cBioVaM cultivation systems. The endothelial cell type character of seeded hCBEC, tested by a Dil-Ac-LDL uptake assay, revealed a vesicular staining pattern inside all adherent cells in both BioVaM and cBioVaM ( Figure 6A) . After 14 d of perfusion cultivation, extensive repopulated vessel structures were found. In BioVaM, mainly linear structures with a maximum length of 6 mm were present (n ¼ 3) (Figure 4C) , whereas in cBioVaM (n ¼ 3) the vessel structures were widely interconnected covering an area up to 56 mm 2 ( Figure 4D) . Comparison of the repopulation process in coated and uncoated patches after 14 d of cultivation revealed an arbitrary value of 3.3 + 0.5 AU for BioVaM and 5.0 + 0.0 AU for cBioVaM ( Table 1) . In parallel to an increase in re-endothelialization, lactate concentrations increased as well ( Figure 5B ). After 14 d in cBioVaM systems, the lactate concentration was seven times higher than in BioVaM and reached 16.5 + 12.3 and 1.6 + 0.6 mmol/L, respectively. Similar to data collected after 4 d, the Dil-Ac-LDL assays after 14 d, resulted in positive stains for all constructs, e.g. a representative vesicular pattern inside all adherent cells ( Figure 6A) , indicative of the maintenance of an endothelial cell character 14 d post-seeding of hCBEC. Supporting evidence for this observation was determined using immunohistochemical analysis against eNOS, CD31, and vWF ( Figure 6B -G) .
Discussion
Herein, we present the successful repopulation of a decellularized vascular bed with endothelial cells differentiated from hCBEC. This construct, i.e. a carrier matrix with a perfusable endothelial cell lined vessel system, may serve as a basis for many approaches to generate artificial tissue by means of TE.
Despite several efforts, a satisfactory solution for the nourishment of 3D tissue has not yet been elucidated. In particular and with respect to the reconstruction of highly nourished native tissues with high oxygen and substrate demand like the myocardium, an efficient supply is indispensable. In the case of reconstructing cardiac muscle, only an efficient, hollow fibre-based perfusion system can provide the required demands. Such a system would minimize the distance between medium and cells within the 3D construct, thereby enhancing the exchange of nutrients, oxygen, and metabolites between the cells and medium. 30 The solution to the nourishment of generated artificial tissue for in vivo TE remains equivocal. Morritt et al.
14 reported the in vivo vascularization of cardiac tissue by ectopic transplantation to the groin of rats. By this method, it was possible to increase the thickness of the construct up to 2 mm. Although such an approach is promising, the required thickness for constructs to be ultimately used in the future therapeutic application in humans has not yet been achieved. Beyond the demand for highly vascularized 3D engineered tissue, defined tubes for anastomosis must be provided for in situ application in therapeutic approaches. Such anastomical connections are necessary to assure rapid and immediate nourishment of the artificial tissue to prevent necrosis after transplantation. BioVaM matrices, our approach to solving these problems, are promising to assure both the creation of an in vitro vascularized vessel bed, in addition to providing defined vessels for anastomosis in situ.
Already in 2005, the feasibility of repopulating vessel bed structures of decellularized BioVaM was demonstrated; 17 however, an incomplete lining of the vessels was observed. Targeting a revascularized BioVaM with non-thrombogenic properties for in vivo applications, we pursued an alternative strategy using re-endothelialized vessel structures. First, we conducted the re-seeding process on a longitudinally opened BioVaM in an advanced bioreactor system, and second, we exposed the lumen of the vessel bed to CCN1, which we believed would additionally support and promote the repopulation process of the vessel bed. CCN1 is a 42 kDa, secreted cystein-rich, heparin binding, extracellular matrix, and cell surface-associated protein. 31 -33 It has been shown that CCN1 mediates adhesion, 21 -23 migration, 19 and proliferation of endothelial cells. 23, 24 In vivo, the angiogenic effect of CCN1
has been demonstrated in a rat corneal micropocket angiogenesis model 19 and the rabbit ischaemic hindlimb model. 34 Furthermore, high CCN1 expression is found in atherosclerotic plaques 35 and postmyocardial infarction 36 and may induce neovascularization of hypoxic areas. Here we demonstrated that recombinant CCN1 enhanced adhesion of hCBEC to matrix components, i.e. collagen IV and laminin present in decellularized vessel walls of BioVaM in cell culture dishes in vitro. In addition, we show that CCN1 in the CCN1 improves vascularized matrix endothelialization absence of these matrix components is not able to induce hCBEC adherence to cell culture dishes, suggesting that CCN1 only improves endothelial cell adherence to vessel walls with intact matrix components. It has been demonstrated previously for various cell types that CCN1 improves cell angio-and vasculogenic properties via integrins. 21, 37, 38 In the present study, we confirmed that enhanced adhesion of hCBEC by CCN1 was mediated by integrins since this effect was abolished by the unspecific integrin inhibitor RGD. The specific integrin types involved in hCBEC adhesion will be explored in future studies. In TE, a cell free matrix with well-preserved ECM, specifically an intact basal membrane, might be a prerequisite for successful repopulation with cells, in order to yield the best results. Therefore, we analysed the decellularized matrix, as well as the integrity of the basal membranes of the BioVaM prior to in vitro seeding with endothelial cells. H&E stains indicated the absence of cells and debris emphasizing an effective mechanical and detergent decellularization protocol. Furthermore, both basal lamina proteins, laminin and collagen IV, were found in the matrix on the luminal side of the vessel bed as indicated by immunohistochemical stains. Thus, seeded hCBEC are presented with a well-preserved basal membrane representing an appropriate surface for endothelial cell adhesion.
Immunofluorescence staining provided evidence of the successful coating of the BioVaM vessel structures by CCN1. The increased number of attached cells on the CCN1-enriched collagen, relative to the population of adhered cells on the collagen coating alone, illustrated the impact of CCN1 on the adhesion behaviour of hCBEC. Furthermore, the increased seeding efficiency and increased DNA content of the cBioVaM vessel structures relative to the BioVaM also indicate improved hCBEC adhesion.
Employing an arbitrary quantification system, results clearly show that the coverage of the vessel structures exposed to CCN1 with endothelial cells is superior to those without CCN1 exposure both at 4 and 14 d. This comparison of cBioVaM vs. the untreated BioVaM suggests at least, a more rapid process of repopulation. Since the 'time' factor is an essential issue in TE, the use of CCN1 represents a very important improvement towards the in vivo application of such constructs. However, even with CCN1 coating, a complete re-endothelialization was not achieved in our experimental settings by 14 d of culture. Here, the additional time for creating an implantable, functional tissue, i.e. contractile heart tissue by adding cardiomyocytes in vitro, has to be accompanied by an additional (neo)-vascularization process.
Characterization of the seeded BioVaMs suggested that the cells lining the vessel structures were of an endothelial nature, as the uptake of Dil-Ac-LDL resulted in a typical dotted, vesicular patterning. This suggests that the cultivation system used in our study perpetuates the differentiation of hCBEC. Furthermore, eNOS, CD31, and vWF, typical endothelial cell-specific markers, could be detected in vessel structures of cultivated BioVaM further supporting a maintained endothelial differentiation as well. An approximate seven-fold increase in lactate concentration in cultures obtained from cBioVaM patches suggests a higher metabolic activity relative to those in uncoated patches. One can speculate that in addition to a reduced time for re-endothelialization, CCN1 may also positively affect viability of cells seeded onto cBioVaM. 20 We conclude that hCBEC, even after 14 d of culture,
were not inhibited by contact inhibition, oxygen, or nutrient demand, since lactate concentrations were continuously increasing, without reaching a steady state level. Targeting an improvement of an overall endothelialization for successful implantation in vivo with this extended growth of hCBEC is noteworthy. Taken together, these data suggest an enhanced quantity of cells within the vessel structures. As an increase in adhered cells does not necessarily mean an improved overall function of the patch, assessment of the quality of the cells in the vessels is currently being investigated. In summary, we report a cultivation system for the generation of a perfusable, endothelialized matrix for the TE of artificial tissues in vitro. Ultimately, further progression and innovation with this system will significantly improve the success of engineered tissue constructs for therapeutic applications.
